Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-(2,2-difluoro-2H-1,3-benzodioxol-5-yl)urea | 2165324-62-7 | MFCD32667017 | 99.4% | C15H8ClF5N2O3 | 10MG
SDP

Supplier:  Medchemexpress LLC HY13311910MG

Encompass_Preferred

PK150 is an orally bioavailable Sorafenib analogue that exhibits potent antibacterial activity against Staphylococcus aureus strains, including MSSA, MRSA, and VISA, with minimum inhibitory concentrations in the submicromolar range. It is supplied for research use and is intended for biochemical and microbiological studies.

  • Orally bioavailable Sorafenib analogue.
  • Active against MSSA, MRSA, and VISA at submicromolar MICs.
  • High reported purity suitable for research applications.
  • Available in multiple small-scale packaging sizes for laboratory use.
  • Chemical formula C15H8ClF5N2O3, molecular weight 394.68.

Catalog No. 50-002-59196


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.